RGNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

REGENXBIO (RGNX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGNX is expected to report earnings to fall 3.42% to -112 cents per share on March 04

Q4'24

Est.

$-1.13

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.24

Q1'24

Missed

by $0.12

Q4'23

Missed

by $0.16

The last earnings report on November 06 showed earnings per share of -116 cents, missing the estimate of -112 cents. With 485.75K shares outstanding, the current market capitalization sits at 419.65M.

View a ticker or compare two or three

Compare

RGNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGNX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RGNX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9804 Medical Center Drive

Phone

+1 240 552-8181

Employees

344

Web

https://www.regenxbio.com